|
Market Closed -
Euronext Paris
11:55:00 2026-11-03 EST
|
5-day change | 1st Jan Change | ||
| 0.4175 EUR | -1.30% |
|
+5.56% | +202.54% |
| 10-12 | Valerio Therapeutics Finalizes Purchase of Etherna Immunotherapies | MT |
| 10-07 | Valerio Therapeutics Société anonyme completed the acquisition of eTheRNA immunotherapies NV. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 233M | - | - | - | - | - |
| 1,255B | |||||
| 641B | |||||
| 505B | |||||
| 381B | |||||
| 357B |
- Stock Market
- Stocks
- ALVIO Stock
- Charts Valerio Therapeutics
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
